Arch Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2011 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Arch Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2011 to Q2 2024.
  • Arch Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 4.44M shares, a 247% increase year-over-year.
  • Arch Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 220M shares, a 17% increase from 2020.
  • Arch Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2020 was 188M shares.
  • Arch Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2014 was 67.5M shares, a 216% increase from 2013.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 4.44M +3.16M +247% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q2 2023 1.28M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2020 187M +23.6M +14.5% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-05
Q3 2019 173M +12.8M +8.01% Jul 1, 2019 Sep 30, 2019 10-K 2020-12-11
Q2 2019 168M +17.8M +11.9% Apr 1, 2019 Jun 30, 2019 10-K 2020-12-11
Q1 2019 163M +13M +8.64% Jan 1, 2019 Mar 31, 2019 10-K 2020-12-11
Q4 2018 161M +10.9M +7.27% Oct 1, 2018 Dec 31, 2018 10-K 2020-12-11
Q3 2018 160M Jul 1, 2018 Sep 30, 2018 10-K 2019-11-19
Q2 2018 151M Apr 1, 2018 Jun 30, 2018 10-K 2019-11-19
Q1 2018 150M Jan 1, 2018 Mar 31, 2018 10-K 2019-11-19
Q4 2017 150M +14.8M +11% Oct 1, 2017 Dec 31, 2017 10-K 2019-11-19
Q4 2016 135M Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-01
Q2 2015 76.8M +4.86M +6.75% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-07
Q1 2015 76.1M +8.73M +13% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-07
Q4 2014 73.3M +13.2M +21.9% Oct 1, 2014 Dec 31, 2014 10-Q 2015-02-09
Q3 2014 67.5M +46.1M +216% Jul 1, 2014 Sep 30, 2014 10-K 2014-12-12
Q2 2014 71.9M +63.4M +742% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 67.3M +61.7M +1093% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 60.1M +54.5M +965% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-09
Q3 2013 21.4M +15.7M +278% Jul 1, 2013 Sep 30, 2013 10-K 2014-12-12
Q2 2013 8.55M +2.91M +51.6% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
Q1 2013 5.65M +1.65M +41.1% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 5.65M +1.65M +41.1% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q3 2012 5.65M Jul 1, 2012 Sep 30, 2012 10-K/A 2014-05-01
Q2 2012 5.64M +1.64M +41% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 4M +4M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-20
Q4 2011 4M Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-14
Q2 2011 4M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 0 Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.